Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-Class Lupus Treatment ...Middle East

COPENHAGEN, Denmark and NEW YORK, June 1, 2022 /PRNewswire/ --The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive results from a Phase 2 trial of its investigational agent deucravacitinib for the treatment...

Read More Details
Finally We wish PressBee provided you with enough information of ( Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-Class Lupus Treatment )

Also on site :

• Woman arrested for gathering intel near Crimean Bridge – FSB
• Russia and UN official discuss steps to end Sudan conflict
• Pepperidge Farm Launches 'Awesome' New Goldfish Flavor, Revives a Favorite